3 Results for "

CETP; ASCVD

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "CETP; ASCVD" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-18778
CAS No.: 866399-87-3
Synonyms: TA-8995; DEZ-001; AMG-899
Research Areas:  

Cardiovascular Disease

Obicetrapib (TA-8995; DEZ-001) is an orally active cholesteryl ester transfer protein (CETP) inhibitor. Obicetrapib potently reduces atherogenic lipoproteins (such as LDL-C, ApoB, Lp (a)) and increases HDL-C. Obicetrapib can be used for the research of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD) .
loading...
    loading...
Cat. No.: HY-18778A
CAS No.: 866399-88-4
Synonyms: TA-8995 sodium; DEZ-001 sodium; AMG-899 sodium
Research Areas:  

Cardiovascular Disease

Obicetrapib (TA-8995; DEZ-001) sodium is an orally active cholesteryl ester transfer protein (CETP) inhibitor. Obicetrapib sodium potently reduces atherogenic lipoproteins (such as LDL-C, ApoB, Lp (a)) and increases HDL-C. Obicetrapib sodium can be used for the research of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD) .
loading...
    loading...
Cat. No.: HY-18778B
CAS No.: 866399-90-8
Synonyms: TA-8995 potassium; DEZ-001 potassium; AMG-899 potassium
Research Areas:  

Metabolic Disease

Obicetrapib (TA-8995; DEZ-001) potassium is an orally active cholesteryl ester transfer protein (CETP) inhibitor. Obicetrapib potassium potently reduces atherogenic lipoproteins (such as LDL-C, ApoB, Lp (a)) and increases HDL-C. Obicetrapib potassium can be used for the research of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD) .
loading...
    loading...